Tenofovir Pharmacokinetics in HIV-infected Thai Adults With Moderate Renal Function Impairment Receiving Either Efavirenz-based or Lopinavir/Ritonavir-based Antiretroviral Therapy.

Trial Profile

Tenofovir Pharmacokinetics in HIV-infected Thai Adults With Moderate Renal Function Impairment Receiving Either Efavirenz-based or Lopinavir/Ritonavir-based Antiretroviral Therapy.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2015

At a glance

  • Drugs Tenofovir (Primary) ; Efavirenz; Lamivudine; Lopinavir/ritonavir
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Acronyms ALTER
  • Most Recent Events

    • 06 Mar 2014 Status changed from recruiting to completed. based on publication of results.
    • 06 Mar 2014 Results presented at the 21st Conference on Retroviruses and Opportunistic Infections.
    • 28 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top